INSIGHTS ON DRUG DEVELOPMENT
-
![GettyImages-1371925389-lab-scientist-collaboration-computer-clipboard]( "Overcoming Excipient Risks And Challenges For Parenteral Formulations")
Overcoming Excipient Risks And Challenges For Parenteral FormulationsExcipients are essential to parenteral formulations, which help protect APIs, enhance stability, and ensure safety. Learn how strategic excipient selection can optimize drug performance and patient outcomes.
-
![Ionizable Lipids To Optimize RNA-LNP Delivery]( "Optimize Your RNA-LNP Delivery With Ionizable Lipids")
Optimize Your RNA-LNP Delivery With Ionizable LipidsIonizable lipids play a crucial role in optimizing LNP delivery. Discover how lipid nanoparticles revolutionize intracellular drug delivery to enhance RNA vaccines, cell therapies, protein replacement, and gene editing.
-
![organ chip drug development thumb]( "Organ-Chips For Drug Development")
Organ-Chips For Drug DevelopmentDelve into how Organ-on-Chip technology significantly enhances drug development processes and improves the accuracy of clinical translation, leading to more effective and reliable therapeutic outcomes.
-
![adare drug dev]( "New Approaches To Tailored Release Profiles")
New Approaches To Tailored Release ProfilesTailored drug release is evolving from formulation tactic to precision therapy strategy, optimizing timing, site, and rate of delivery for improved patient outcomes.
-
Tips And Tricks Addressing PCR Pain Points3/5/2026
qPCR workflows are vital but prone to common errors. Improve the precision and reliability of your gene expression data by mastering key strategies to overcome frequent experimental pitfalls.
-
Cell Culture Media Demystified For Performance, Quality, And Innovation11/13/2025
Cell culture media isn’t one-size-fits-all. Learn how media composition, customization, and analytics can dramatically improve cell growth, productivity, and product quality for complex processes.
-
Strategic Early Material Generation For Accelerated Process Development5/14/2026
Learn how early material generation strategies can accelerate biologics development, streamline process optimization, and enable scalable, production-relevant material supply from the earliest stages of development.
-
Spray Dried Biologics For Injectable Dosage Forms5/15/2026
Spray drying enables scalable production of stable, high‑concentration biologics as sterile powders, improving delivery, reducing costs, and overcoming limitations of traditional freeze‑drying methods.
-
Transforming Research Through Lab Automation7/6/2026
Self-driving labs bring automation and AI together to transform research. Learn about how continuous experimentation and real-time learning unlock faster insights and more efficient paths to innovation.
DRUG DEVELOPMENT SOLUTIONS
-
![Microcalorimetry TA Instruments]( "Microcalorimetry: RS-DSC, DSC & ITC")
DSC and ITC offer deep insights into molecular binding and structural stability, which help researchers uncover thermodynamic drivers and domain-level behavior essential for protein characterization.
-
![adarapharma2]( "Adare Pharma Solutions (APS) Orbis Overview")
Orbis provides innovative taste-making and controlled release solutions for oral and injectable pharmaceutical products.
-
![GettyImages-1302287478-powder-excipient-petri-dish]( "Enhance Dissolution Rate With A Single High Performance Excipient")
Enhance dissolution and lubrication in solid oral formulations. See how this approach supports poorly soluble actives, modern manufacturing methods, and consistent performance.
-
![micronization]( "Small Scale, R&D Micronization Equipment")
The systems can be provided in sterile, toxic or sterile toxic arrangements with the great advantage of being 100 % scalable.
-
![leica-microsystems-aivia-hero]( "AI Image Analysis Software")
Access the future of AI microscopy
Subjectivity of analysis and poor reproducibility are key hurdles to be overcome for biological image analysis. Standard segmentation can lead to sub-standard results and require substantial manual curation which is subject to human error.
